Bringing the fundamentals into focus…
Back to MeiraGTx Holdings plc
How MeiraGTx Holdings plc stacks up
MGTX · against 489 other Healthcare companies of similar size
Valuation
94/ 100
Near the top of its peers.
Ranked #29 of 490 · scores higher than 93% of peers
Bars: peers in each 10-point band of the valuation score51 peers with a valuation score of 90–100, including MGTX · Click a bar to see the companies
Why valuation scores 94?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its EBITDA yield and earnings yield, which are stronger than most Healthcare peers.
- Free cash flow yield is close to the peer norm. Free cash flow yield: 1.1% vs peer median 0.0%
- higher earnings for the price paid: stronger than 94% of peers. Earnings yield: 8.6% vs peer median 1.5%
- more operating profit (EBITDA) for the company's total value: stronger than 96% of peers. EBITDA yield: 22.5% vs peer median 4.0%
Metric by metric
Position: dot = MGTX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | MGTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 478 reported | 9.1% | 1.2% | 95% | 30% | |
| EBITDA yieldHigher is better · 496 reported | 22.2% | 4.1% | 97% | 50% | |
| Free cash flow yieldHigher is better · 211 reported | -1.5% | -2.7% | 55% | 20% | |
| Book yieldHigher is better · 487 reported | 24.0% | 41.6% | 25% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around MGTXScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score